Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
Epidural chloroprocaine is often used in obstetrical anesthesia because of its fast onset and short duration. These properties make it an ideal drug to use for epidural anesthesia in patients undergoing postpartum tubal ligation. When epidural morphine is given after chloroprocaine, there is a decreased efficacy of analgesia as compared to lidocaine (1). Several studies have hypothesized a specific opioid receptor mediated antagonism of chloroprocaine (2,3). Karambelkar raised the question whether this decreased efficacy is due to a disparity between the time the chloroprocaine anesthesia resolves and the onset of epidural morphine analgesia, resulting in a time window of pain (2). The duration of action of epidural 2-CP anesthesia is 30-45 minutes and the onset of epidural morphine analgesia is 60-70 minutes, therefore the regression of sensory blockade before the onset of the morphine analgesia could result in a window of pain (2). Hess and colleagues studied epidural morphine analgesia and women who had a Cesarean delivery under spinal bupivacaine anesthesia (3). Subjects were randomized to receive epidural 2-CP and morphine or epidural saline and morphine. There was no difference in postoperative analgesia between the two groups (3 and personal communication, Dr. Philip Hess). A literature search cross referencing epidural chloroprocaine, using Pub Med, did not produce any articles comparing epidural morphine given before the procedure (in an attempt to time the onset of analgesia with the resolution of chloroprocaine anesthesia) to the standard administration time after the procedure.
| Condition | Intervention |
|---|---|
|
Labor Analgesia, Epidural |
Drug: Morphine-CP-saline (MCS) Drug: saline-2CP-morphine (SCM) Drug: saline-lidocaine-morphine (SLM) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | Interaction Between Epidural 2-chloroprocaine and Epidural Morphine: Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia |
- Duration of Continuing Analgesia [ Time Frame: 48 hours ] [ Designated as safety issue: No ]Time to first request for supplemental analgesia
- Supplemental Analgesia in First 90 Minutes [ Time Frame: 90 min ] [ Designated as safety issue: No ]Participants requesting supplemental analgesia in the first 90 minutes following study drug
- Verbal Rating Score (0 to 10) for Pain (VRPS) [ Time Frame: At recovery room entry ] [ Designated as safety issue: No ]Verbal Rating Pain Score (VRPS) at time of post-anesthesia recovery room entry, where 0 = no pain and 10 = worst pain imaginable
- Supplemental Analgesia in First 48 Hours [ Time Frame: 48 hours ] [ Designated as safety issue: No ]Participants requesting supplemental analgesia in first 48 hours
| Enrollment: | 136 |
| Study Start Date: | August 2004 |
| Study Completion Date: | September 2008 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: morphine - 2CP-saline (MCS)
morphine will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level; saline will be administered at skin incision
|
Drug: Morphine-CP-saline (MCS)
3mg of preservative free morphine will be administered epidurally 30 min prior to epidural anesthesia. Epidural 3% 2CP will be used to achieve a T4 dermatomal level for surgical anesthesia for PPTL. 6ml of epidural saline will be administered at skin incision
|
|
Experimental: saline-2CP-morphine (SCM)
saline will be administered 30 min prior to epidural anesthesia; 2CP will be used to achieve a T4 level;morphine will be administered at skin incision
|
Drug: saline-2CP-morphine (SCM)
6ml of saline will be administered epidurally 30 min prior to epidural anesthesia. Epidural 3% 2CP will be used to achieve a T4 dermatomal level for surgical anesthesia for PPTL. 3mg of preservative free morphine will be administered at skin incision
|
|
Active Comparator: saline-lidocaine-morphine (SLM)
Saline will be administered 30 min prior to epidural anesthesia; lidocaine will be used to achieve a T4 level; morphine will be administered at skin incision
|
Drug: saline-lidocaine-morphine (SLM)
3mg of preservative free morphine will be administered epidurally 30 min prior to epidural anesthesia. Epidural 2% lidocaine with epinephrine 1:200,000 will be used to achieve a T4 dermatomal level for surgical anesthesia for PPTL. 6ml of epidural saline will be administered at skin incision
|
Detailed Description:
Women undergoing post partum tubal ligation with an epidural in-situ will be randomly double blindedly selected into one of three groups for pain control. The groups are epidural 1) epidural morphine-chloroprocaine 2) epidural chloroprocaine-morphine 3) epidural morphine-lidocaine. Groups 1 and 3 will receive morphine 30 minutes prior to local anesthetic dosing followed by saline placebo after local dosing. Group 2 will receive placebo 30 minutes prior to local anesthetic dosing followed by epidural morphine. Pain scores and supplemental analgesic requirements will be evaluated 30 minutes, 1hr, 2hr, 4hr and every 4 hrs for the first 24hrs.
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- All patients with an epidural catheter in situ for labor analgesia, status post a vaginal delivery, and scheduled for a postpartum tubal ligation under epidural anesthesia will be eligible
Exclusion Criteria:
- Allergy/hypersensitivity to morphine
- Allergy/hypersensitivity to ester-linked local anesthetics or para-amino benzoic acid (PABA)
- Body Mass Index >40 kg/m2
- Patients using chronic opioids
- History of obstructive sleep apnea
- Any contraindication to epidural anesthesia
Contacts and Locations| United States, Illinois | |
| Northwestern University | |
| Chicago, Illinois, United States, 60611 | |
| Principal Investigator: | Cynthia A Wong, M.D. | Northwestern University |
More Information
Publications:
| Responsible Party: | Cynthia A. Wong, M.D., Northwestern University |
| ClinicalTrials.gov Identifier: | NCT00487084 History of Changes |
| Other Study ID Numbers: | 0524-021 |
| Study First Received: | June 13, 2007 |
| Results First Received: | February 9, 2011 |
| Last Updated: | May 9, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Northwestern University:
|
analgesia tubal ligation chloroprocaine |
Additional relevant MeSH terms:
|
Anesthetics Lidocaine Chloroprocaine Procaine Morphine Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents |
Therapeutic Uses Anesthetics, Local Sensory System Agents Peripheral Nervous System Agents Anti-Arrhythmia Agents Cardiovascular Agents Analgesics, Opioid Analgesics Narcotics |
ClinicalTrials.gov processed this record on June 18, 2013